# Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-tapentadol-prolonged-release-compared-with-oxycodone/

## Facts

| Field | Value |
| --- | --- |
| Author Names | R. Ikenberg,N. Hertel,Andrew Moore,M Obradović,Garth Baxter,Pete Conway,Hiltrud Liedgens |
| Citations | 28 |
| DOI | 10.3111/13696998.2012.670174 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.3111/13696998.2012.670174?needAccess=true |
| OpenAlex ID | https://openalex.org/W2169043109 |
| PMID | 22364286 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Garth Baxter](https://scholariq.org/researchers/garth-baxter/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Opioid Use Disorder Treatment](https://scholariq.org/topics/opioid-use-disorder-treatment/)

## Paper topics

- [Opioid Use Disorder Treatment](https://scholariq.org/topics/opioid-use-disorder-treatment/)
- [Pain Management and Opioid Use](https://scholariq.org/topics/pain-management-and-opioid-use/)
- [Musculoskeletal pain and rehabilitation](https://scholariq.org/topics/musculoskeletal-pain-and-rehabilitation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.